{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:40:45Z","timestamp":1793252445724,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008184","name":"COPD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial lung abnormalities (ILA) are radiologic findings that may progress to idiopathic pulmonary fibrosis (IPF). Blood gene expression profiles can predict IPF mortality, but whether these same genes associate with\u00a0ILA\u00a0and\u00a0ILA\u00a0outcomes is unknown. This study evaluated if a previously described blood gene expression profile associated with IPF mortality is associated with\u00a0ILA\u00a0and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In COPDGene and ECLIPSE study participants with visual scoring of\u00a0ILA\u00a0and gene expression data, we evaluated the association of a previously described IPF mortality score with\u00a0ILA\u00a0and mortality. We also trained a new\u00a0ILA\u00a0score, derived using genes from the IPF score, in a subset of COPDGene. We tested the association with\u00a0ILA\u00a0and mortality on the remainder of COPDGene and ECLIPSE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 1469 COPDGene (training n\u2009=\u2009734; testing n\u2009=\u2009735) and 571 ECLIPSE participants, the IPF score was not associated with\u00a0ILA\u00a0or mortality. However, an\u00a0ILA\u00a0score derived from IPF score genes was associated with\u00a0ILA\u00a0(meta-analysis of test datasets OR 1.4 [95% CI: 1.2\u20131.6]) and mortality (HR 1.25 [95% CI: 1.12\u20131.41]). Six of the 11 genes in the\u00a0ILA\u00a0score had discordant directions of effects compared to the IPF score. The\u00a0ILA\u00a0score partially mediated the effects of age on mortality (11.8% proportion mediated).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An\u00a0ILA\u00a0gene expression score, derived from IPF mortality-associated genes, identified genes with concordant and discordant effects on IPF mortality and\u00a0ILA. These results suggest shared, and unique biologic processes, amongst those with ILA, IPF, aging, and death.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-02077-8","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:23:37Z","timestamp":1655436217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Matthew","family":"Moll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auyon J.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Putman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McGeachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don D.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Hatabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Hunninghake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"2077_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMoa1007285","volume":"364","author":"GR Washko","year":"2011","unstructured":"Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897\u2013906.","journal-title":"N Engl J Med"},{"key":"2077_CR2","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","volume":"368","author":"GM Hunninghake","year":"2013","unstructured":"Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368:2192\u2013200.","journal-title":"N Engl J Med"},{"key":"2077_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","volume":"8","author":"H Hatabu","year":"2020","unstructured":"Hatabu H, Hunninghake GM, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med. 2020;8:726\u201337.","journal-title":"Lancet Respir Med"},{"key":"2077_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","volume":"200","author":"RK Putman","year":"2019","unstructured":"Putman RK, Gudmundsson G, Axelsson GT, et al. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality. Am J Respir Crit Care Med. 2019;200:175\u201383.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","volume":"194","author":"T Araki","year":"2016","unstructured":"Araki T, Putman RK, Hatabu H, et al. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016;194:1514\u201322.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.201109-1618OC","volume":"185","author":"TJ Doyle","year":"2012","unstructured":"Doyle TJ, Washko GR, Fernandez IE, et al. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med. 2012;185:756\u201362.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1164\/rccm.200812-1966OC","volume":"180","author":"DJ Lederer","year":"2009","unstructured":"Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med. 2009;180:407\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR8","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.rmed.2010.05.014","volume":"104","author":"K Tsushima","year":"2010","unstructured":"Tsushima K, Sone S, Yoshikawa S, Yokoyama T, Suzuki T, Kubo K. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up. Respir Med. 2010;104:1712\u201321.","journal-title":"Respir Med"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jama.2016.0518","volume":"315","author":"RK Putman","year":"2016","unstructured":"Putman RK, Hatabu H, Araki T, et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA. 2016;315:672\u201381.","journal-title":"JAMA"},{"key":"2077_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1164\/rccm.201903-0511OC","volume":"200","author":"BD Hobbs","year":"2019","unstructured":"Hobbs BD, Putman RK, Araki T, et al. Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200:1402\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00537-2017","author":"RK Putman","year":"2017","unstructured":"Putman RK, Gudmundsson G, Araki T, et al. The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00537-2017.","journal-title":"Eur Respir J"},{"key":"2077_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","volume":"155","author":"KB Baumgartner","year":"1997","unstructured":"Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155:242\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12920-017-0295-9","volume":"10","author":"MM Parker","year":"2017","unstructured":"Parker MM, Chase RP, Lamb A, et al. RNA sequencing identifies novel non-coding RNA and exon-specific effects associated with cigarette smoking. BMC Med Genomics. 2017;10:58.","journal-title":"BMC Med Genomics"},{"key":"2077_CR14","doi-asserted-by":"publisher","first-page":"205ra136","DOI":"10.1126\/scitranslmed.3005964","volume":"5","author":"JD Herazo-Maya","year":"2013","unstructured":"Herazo-Maya JD, Noth I, Duncan SR, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med. 2013;5:205ra136.","journal-title":"Sci Transl Med"},{"key":"2077_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S2213-2600(17)30349-1","volume":"5","author":"JD Herazo-Maya","year":"2017","unstructured":"Herazo-Maya JD, Sun J, Molyneaux PL, et al. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017;5:857\u201368.","journal-title":"Lancet Respir Med"},{"key":"2077_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2011","unstructured":"Regan EA, Hokanson JE, Murphy JR, et al. Genetic Epidemiology of COPD (COPDGene) Study Design. COPD J Chronic Obstr Pulm Dis. 2011;7:32\u201343.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"2077_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1183\/09031936.00111707","volume":"31","author":"J Vestbo","year":"2008","unstructured":"Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008;31:869\u201373.","journal-title":"Eur Respir J"},{"key":"2077_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiol.2018181684","volume":"291","author":"H Hatabu","year":"2019","unstructured":"Hatabu H, Hunninghake GM, Lynch DA. Interstitial lung abnormality: recognition and perspectives. Radiology. 2019;291:1\u20133.","journal-title":"Radiology"},{"key":"2077_CR19","first-page":"204367","volume":"34","author":"A Hata","year":"2021","unstructured":"Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: state of the art. Radiology. 2021;34:204367.","journal-title":"Radiology"},{"key":"2077_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3348\/kjr.2020.1132","volume":"22","author":"T Hino","year":"2021","unstructured":"Hino T, Lee KS, Han J, Hata A, Ishigami K, Hatabu H. Spectrum of pulmonary fibrosis from interstitial lung abnormality to usual interstitial pneumonia: importance of identification and quantification of traction bronchiectasis in patient management. Korean J Radiol. 2021;22:811\u201328.","journal-title":"Korean J Radiol"},{"key":"2077_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2105-15-182","volume":"15","author":"H Jiang","year":"2014","unstructured":"Jiang H, Lei R, Ding S-W, Zhu S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinformatics. 2014;15:182.","journal-title":"BMC Bioinformatics"},{"key":"2077_CR22","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/bioinformatics\/bts196","volume":"28","author":"DS DeLuca","year":"2012","unstructured":"DeLuca DS, Levin JZ, Sivachenko A, et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics. 2012;28:1530\u20132.","journal-title":"Bioinformatics"},{"key":"2077_CR23","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1002\/0471250953.bi1114s51","volume":"51","author":"A Dobin","year":"2015","unstructured":"Dobin A, Gingeras TR. Mapping RNA-seq Reads with STAR. Curr Protoc Bioinforma. 2015;51:11141\u2013111419.","journal-title":"Curr Protoc Bioinforma"},{"key":"2077_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.","journal-title":"Nucleic Acids Res"},{"key":"2077_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12931-017-0558-1","volume":"18","author":"M Obeidat","year":"2017","unstructured":"Obeidat M, Nie Y, Chen V, et al. Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Res. 2017;18:72.","journal-title":"Respir Res"},{"key":"2077_CR26","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26:2363\u20137.","journal-title":"Bioinformatics"},{"key":"2077_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249\u201364.","journal-title":"Biostatistics"},{"key":"2077_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/bioinformatics\/btl033","volume":"22","author":"S Hochreiter","year":"2006","unstructured":"Hochreiter S, Clevert D-A, Obermayer K. A new summarization method for Affymetrix probe level data. Bioinformatics. 2006;22:943\u20139.","journal-title":"Bioinformatics"},{"key":"2077_CR29","doi-asserted-by":"publisher","DOI":"10.1079\/IVPt200454()IN","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc Ser B. 1972. https:\/\/doi.org\/10.1079\/IVPt200454()IN.","journal-title":"J R Stat Soc Ser B"},{"key":"2077_CR30","unstructured":"T T. A Package for Survival Analysis in R. R package version 3.1\u201312. https:\/\/CRANR-project.org\/package=survival 2020."},{"key":"2077_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"2077_CR32","first-page":"40","volume":"7","author":"S Gan","year":"2007","unstructured":"Gan S. meta: An R package for meta-analysis. R News. 2007;7:40\u20135.","journal-title":"R News"},{"key":"2077_CR33","first-page":"1","volume":"76","author":"S Johan","year":"2017","unstructured":"Johan S, Tom L, Beatrijs MSV. medflex: An R Package for Flexible Mediation Analysis using Natural Effect Models. J Stat Softw. 2017;76:1\u201346.","journal-title":"J Stat Softw"},{"key":"2077_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/aje\/kwr525","volume":"176","author":"T Lange","year":"2012","unstructured":"Lange T, Vansteelandt S, Bekaert M. A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol. 2012;176:190\u20135.","journal-title":"Am J Epidemiol"},{"key":"2077_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/2161-962X.1014","volume":"1","author":"S Vansteelandt","year":"2012","unstructured":"Vansteelandt S, Bekaert M, Lange T. Imputation strategies for the estimation of natural direct and indirect effects. Epidemiol Method. 2012;1:7.","journal-title":"Epidemiol Method"},{"key":"2077_CR36","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.229","volume":"1","author":"ABK Foroushani","year":"2013","unstructured":"Foroushani ABK, Brinkman FSL, Lynn DJ. Pathway-GPS and SIGORA: identifying relevant pathways based on the over-representation of their gene-pair signatures. PeerJ. 2013;1: e229.","journal-title":"PeerJ"},{"key":"2077_CR37","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1073\/pnas.97.4.1778","volume":"97","author":"N Kaminski","year":"2000","unstructured":"Kaminski N, Allard JD, Pittet JF, et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A. 2000;97:1778\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2077_CR38","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202008-3093OC","author":"Y Huang","year":"2021","unstructured":"Huang Y, Oldham JM, Ma S-F, et al. Blood transcriptomic predicts progression of pulmonary fibrosis and associates natural killer cells. Am J Respir Crit Care Med. 2021. https:\/\/doi.org\/10.1164\/rccm.202008-3093OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/thoraxjnl-2013-204596","volume":"70","author":"DJ DePianto","year":"2015","unstructured":"DePianto DJ, Chandriani S, Abbas AR, et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax. 2015;70:48\u201356.","journal-title":"Thorax"},{"key":"2077_CR40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2019","unstructured":"Reyfman PA, Walter JM, Joshi N, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199:1517\u201336.","journal-title":"Am J Respir Crit Care Med"},{"key":"2077_CR41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1172\/JCI0214685","volume":"109","author":"M Huang","year":"2002","unstructured":"Huang M, Sharma S, Zhu LX, et al. IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest. 2002;109:931\u20137.","journal-title":"J Clin Invest"},{"key":"2077_CR42","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1365-2222.2005.02383.x","volume":"35","author":"AJ Morgan","year":"2005","unstructured":"Morgan AJ, Guillen C, Symon FA, et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy. 2005;35:1572\u201380.","journal-title":"Clin Exp Allergy"},{"key":"2077_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12931-021-01646-7","volume":"22","author":"Z Ma","year":"2021","unstructured":"Ma Z, Ma C, Zhang Q, et al. Role of CXCL16 in BLM-induced epithelial-mesenchymal transition in human A549 cells. Respir Res. 2021;22:42.","journal-title":"Respir Res"},{"key":"2077_CR44","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.celrep.2018.03.010","volume":"22","author":"T Xie","year":"2018","unstructured":"Xie T, Wang Y, Deng N, et al. Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis. Cell Rep. 2018;22:3625\u201340.","journal-title":"Cell Rep"},{"key":"2077_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1153","volume":"9","author":"T Miles","year":"2020","unstructured":"Miles T, Hoyne GF, Knight DA, Fear MW, Mutsaers SE, Pr\u00eale CM. The contribution of animal models to understanding the role of the immune system in human idiopathic pulmonary fibrosis. Clin Transl Immunol. 2020;9: e1153.","journal-title":"Clin Transl Immunol"},{"key":"2077_CR46","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ajpath.2012.01.010","volume":"180","author":"DJ Kass","year":"2012","unstructured":"Kass DJ, Yu G, Loh KS, et al. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am J Pathol. 2012;180:1963\u201378.","journal-title":"Am J Pathol"},{"key":"2077_CR47","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-019-1462-z","volume":"10","author":"D Qiu","year":"2019","unstructured":"Qiu D, Chu X, Hua L, et al. Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice. Cell Death Dis. 2019;10:233.","journal-title":"Cell Death Dis"},{"key":"2077_CR48","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1128\/MCB.00789-07","volume":"27","author":"M Attia","year":"2007","unstructured":"Attia M, Rachez C, De Pauw A, Avner P, Rogner UC. Nap1l2 promotes histone acetylation activity during neuronal differentiation. Mol Cell Biol. 2007;27:6093\u2013102.","journal-title":"Mol Cell Biol"},{"key":"2077_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122091","author":"L Plantier","year":"2016","unstructured":"Plantier L, Renaud H, Respaud R, Marchand-Adam S, Crestani B. Transcriptome of cultured lung fibroblasts in idiopathic pulmonary fibrosis: meta-analysis of publically available microarray datasets reveals repression of inflammation and immunity pathways. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17122091.","journal-title":"Int J Mol Sci"},{"key":"2077_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fmed.2018.00180","volume":"5","author":"I Ninou","year":"2018","unstructured":"Ninou I, Magkrioti C, Aidinis V. Autotaxin in pathophysiology and pulmonary fibrosis. Front Med. 2018;5:180.","journal-title":"Front Med"},{"key":"2077_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1258\/096914105775220642","volume":"12","author":"NJ Wald","year":"2005","unstructured":"Wald NJ, Morris JK, Rish S. The efficacy of combining several risk factors as a screening test. J Med Screen. 2005;12:197\u2013201.","journal-title":"J Med Screen"},{"key":"2077_CR52","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41436-018-0418-5","volume":"21","author":"NJ Wald","year":"2019","unstructured":"Wald NJ, Old R. The illusion of polygenic disease risk prediction. Genet Med. 2019;21:1705\u20137.","journal-title":"Genet Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02077-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02077-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T13:01:51Z","timestamp":1675861311000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02077-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02077-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.31.22270173","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All COPDGene and ECLIPSE study participants provided written informed consent. Each study center obtained institutional review board (IRB) approval (Mass General Brigham IRB protocol 2007P000554).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MM received grant support from Bayer. EKS received grant support from GlaxoSmithKline and Bayer. CPH reports grant support from Boehringer-Ingelheim, Novartis, Bayer and Vertex, outside of this study. MN has received research grants to the institution from AstraZeneca, Daiichi Sankyo, Canon Medical Systems, and has served as a consultant to AstraZeneca, and Daiichi Sankyo. PJC has received grant support from GlaxoSmithKline and Bayer and consulting fees from GlaxoSmithKline and Novartis. RTS was employed by GlaxoSmithKline until 2019 and is a shareholder of GlaxoSmithKline stock; RTS received consulting fees from Immunomet, ENA Respiratory, Teva, and Vocalis Health; she is currently a Board Member of ENA Respiratory on behalf of the COPD Foundation. JQ is on the scientific advisory boards of Caris Life Sciences and Renalytix. HH received grants from Canon Medical Systems Inc and Konica-Minolta Inc. and served as consultant for Mitsubishi Chemical Co and Canon Medical Systems Inc outside of this study. GMH has performed consulting work for Boehringer-Ingelheim, and the Gerson Lehrman Group within the last 3\u00a0years. MHC has received grant support from GlaxoSmithKline and Bayer, consulting fees from Genentech and AstraZeneca, and speaking fees from Illumina.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}